MedTrace Logo

Advisory Lead ARDS Respirator Management

NCT04274296 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 472

Last updated 2023-10-19

No results posted yet for this study

Summary

A advisory will be activated in the ICUs patient data management system. The trial will be conducted as observational cohort trial. During the first six month all patients with a LIPS ≥ 4 will be included in the control group. No change of care is needed. In a second phase during the next six months, all patients with a LIPS ≥ 4 will be included into the advisory group where advisories will be shown in the patient data management system.

To create this advisory, a clinical advisory rule is executed every 4 hours and the appropriate advisory text is calculated. If the defined threshold values (driving pressure ≥ 15mbar) are reached, then the advisory displays a recommendation to rethink the patient's ventilation strategy. Furthermore, permissive hypercapnia and oxygen saturating limits considered as safe will be given. (paCO2: 55mmHg, pH: 7.25, paO2: 80 mmHg, SaO2: 92%)

Conditions

  • ARDS, Human

Interventions

DEVICE

Activation of Advisory

Advisory is activated which will show if driving pressure is greater or equal 15

Sponsors & Collaborators

  • Philips Austria GmbH

    collaborator UNKNOWN

  • Medical University of Vienna

    collaborator OTHER

  • Mathias Maleczek

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2022-03-28
Completion
2023-01-11
FDA Device
Yes

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04274296 on ClinicalTrials.gov